Stock Spotlight Archives

ThursdayJul 16, 2026 3:42 pm

QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Positions Hopkins for Next Exploration Phase Amid Growing REE Demand

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) has identified multiple high-priority rare earth element (“REE”) exploration targets at its 6,145-hectare Hopkins REE Project in northeastern Ontario following a comprehensive desktop study integrating geological, geophysical, geochemical, and historical data. The analysis highlighted several structurally controlled target zones, with Block A and its A1 target receiving the highest priority for follow-up exploration. The company intends to undertake a phased exploration program, subject to funding, permitting, seasonal conditions, and final program design. Planned work includes airborne surveys, geological mapping, sampling, and, if warranted,…

ThursdayJul 16, 2026 3:16 pm

QualityStocksNewsBreaks – Greenland Energy Company (NASDAQ: GLND) Advances Arctic Exploration with Fully Funded Drilling Program

Greenland Energy (NASDAQ: GLND) was featured in a recent article discussing its fully funded plan to advance exploration of the Jameson Land Basin in East Greenland, a 2.1-million-acre Arctic hydrocarbon project with estimated prospective recoverable resources of up to 13 billion barrels of oil. Backed by millions in fresh capital, the company plans to drill two exploration wells in 2026 under an earn-in agreement that could increase its working interest in the project to 70%. Greenland Energy has assembled experienced drilling, engineering, and Arctic logistics partners to support execution while highlighting the basin’s extensive historical exploration, modern seismic analysis, and grandfathered…

ThursdayJul 16, 2026 2:52 pm

QualityStocksNewsBreaks – Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Poised at the Intersection of AI and Precision Medicine

Cardio Diagnostics Holdings (NASDAQ: CDIO) is leveraging artificial intelligence, epigenetics, and genetics to improve the early detection and diagnosis of coronary heart disease through its blood-based Epi+Gen CHD and PrecisionCHD tests, addressing a cardiovascular disease market projected to grow from $393 billion in annual healthcare costs in 2020 to $1.4 trillion by 2050. The company’s proprietary AI-driven Multi-Omics Engine analyzes genetic and epigenetic biomarkers to assess heart attack risk and identify coronary heart disease, including certain nonobstructive forms that conventional diagnostic methods may miss. Cardio Diagnostics has strengthened its commercialization efforts through securing finalized CMS reimbursement rates and dedicated CPT laboratory codes,…

ThursdayJul 16, 2026 2:25 pm

QualityStocksNewsBreaks – BluSky AI Inc. (BSAI) Unveils Vision for Scalable AI Infrastructure

BluSky AI (OTC: BSAI) is positioning to help address the growing global shortage of AI computing infrastructure through its data center model, which is designed to deliver AI compute capacity more quickly and sustainably than traditional hyperscale facilities. The company’s modular SkyMods, or prefabricated AI factories, require less energy, use little to no water for cooling, occupy smaller footprints, and can be deployed in roughly 12 months while supporting both AI training and the increasing demand for inference workloads. BluSky AI also plans to expand its Neocloud platform with a network of AI Factory locations across the U.S., offering GPU-as-a-Service, bare…

WednesdayJul 15, 2026 3:55 pm

QualityStocksNewsBreaks – Global Constraints Shine Spotlight on Lahontan Gold Corp.’s (TSX.V: LG) (OTCQB: LGCXF) Nevada Development Strategy

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is advancing its Santa Fe Mine project and broader Walker Lane portfolio in Nevada as global gold supply “enters a more complicated era, shaped not only by geology and discovery rates but also by government policy, rising operating costs, safety enforcement, environmental oversight and growing pressure for producing countries to capture more value at home.” With China’s production declining amid safety inspections and maintenance and countries such as Ghana imposing higher royalties and stricter local ownership requirements, stable mining jurisdictions are…

WednesdayJul 15, 2026 3:22 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Positions Navigation Technology for Next Generation of Autonomous Drones

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. As drone hardware becomes increasingly commoditized, software is emerging as the key differentiator driving value across the global drone market. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) is positioning itself at the forefront of this trend with software-based GPS-denied target acquisition and autonomous navigation technologies designed to enhance drone capabilities without requiring additional hardware. The company’s Overwatch platform enables navigation, tracking, and targeting in environments where GPS signals are unavailable or unreliable, with applications spanning defense, search and rescue, and commercial markets. SPARC AI recently strengthened its commercialization efforts…

WednesdayJul 15, 2026 2:43 pm

QualityStocksNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Brings AI and Robotics Together in New Platform

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a recent article that discussed the company’s launch of an AI-powered manufacturing services platform designed to help emerging biotechnology companies overcome one of the industry’s biggest challenges: accessing full GMP infrastructure. “The platform combines Oncotelic’s proprietary PDAOAI(TM) architecture with digital manufacturing technologies and intelligent robotics developed in collaboration with TechForce Robotics, the company’s strategic robotics and automation partner. The goal is not simply to apply AI to drug discovery, but to bring it into the manufacturing workflows that determine whether a therapy moves efficiently from development toward commercialization.” Already deployed at Oncotelic’s GMP-certified SAPU manufacturing facility to…

TuesdayJul 14, 2026 3:24 pm

QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Strengthens Position in Audience Engagement with Winfinite and Filter Fan Cam

Zacks Investment Research recently initiated coverage of Versus Systems (NASDAQ: VS), citing the company’s progress in strengthening its financial performance and advancing its gamification and audience engagement platform. Zacks highlighted improved first-quarter 2026 results, including significantly reduced operating losses and positive operating cash flow, along with potential growth opportunities tied to an extension of Versus’ technology licensing relationship with ASPIS. The company’s Winfinite and Filter Fan Cam platforms combine interactive games, real-world rewards, and augmented reality experiences to help brands, sports organizations, and entertainment companies increase customer engagement across digital and live-event channels. With a growing international footprint and continued product…

TuesdayJul 14, 2026 2:45 pm

QualityStocksNewsBreaks – Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) Targets Next Generation of Space Infrastructure with Mantis Investment

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising. Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) has entered the growing space infrastructure sector with a $200,000 strategic equity investment in Mantis Space, a company developing what it describes as the world’s first orbital power grid. The investment reflects Planet Ventures’ strategy of providing public market investors with exposure to emerging private companies in high-growth industries. Mantis aims to enable satellites to receive wireless power in orbit, potentially reducing spacecraft size, weight and cost while supporting the expanding space economy. The move comes…

TuesdayJul 14, 2026 2:18 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Expands Clinical Development of Neuroprotective Therapy

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) was featured in a recent article that discussed its advancement of its proprietary multiple sclerosis therapy candidate, LUCID-MS, which is designed to target demyelination and protection or restoration of myelin integrity. The company reported that Phase 1 clinical studies in healthy volunteers demonstrated a favorable safety profile and that the therapy was generally well tolerated, supporting advancement into patient-focused studies. In April 2026, Quantum BioPharma submitted an Investigational New Drug application to the U.S. Food and Drug Administration for LUCID-MS, paving the way…

Site Search

Company Search

Category: Stock Spotlight